scholarly journals A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL)

BioDrugs ◽  
2019 ◽  
Vol 34 (2) ◽  
pp. 171-181 ◽  
Author(s):  
Jeff P. Sharman ◽  
Anna Marina Liberati ◽  
Kenichi Ishizawa ◽  
Tahira Khan ◽  
Jeffery Robbins ◽  
...  
2020 ◽  
Vol 15 (5) ◽  
pp. 599-611
Author(s):  
Dietger Niederwieser ◽  
Caroline Hamm ◽  
Patrick Cobb ◽  
Mindy Mo ◽  
Cecily Forsyth ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document